Joseph Oliveto
President and CEO at Milestone Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Milestone Pharmaceuticals Inc., 3 years.
Milestone Pharmaceuticals Inc.
Director · President and CEO
Chief executive roles
Milestone Pharmaceuticals Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | Milestone Pharmaceuticals Inc. | Open-market sale | −36,500 | $2.26 | $82,490 |
| Jan 26, 2026 | Milestone Pharmaceuticals Inc. | Option exercise | +66,600 | — | — |
| Jan 26, 2026 | Milestone Pharmaceuticals Inc. | Open-market sale | −34,523 | $1.93 | $66,629 |
| Jan 8, 2026 | Milestone Pharmaceuticals Inc. | Open-market sale | −43,000 | $2.25 | $96,750 |
| Jan 7, 2026 | Milestone Pharmaceuticals Inc. | Open-market sale | −500 | $2.25 | $1,125 |
| Dec 15, 2025 | Milestone Pharmaceuticals Inc. | Open-market sale | −133,054 | $2.32 | $308,685 |
| Dec 12, 2025 | Milestone Pharmaceuticals Inc. | Grant or award | +280,000 | — | — |
| Jul 11, 2025 | Milestone Pharmaceuticals Inc. | Grant or award | +66,666 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.